![Youssef Lemgendez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Youssef Lemgendez
Direttore/Membro del Consiglio presso PreciThera, Inc.
Provenienza dei contatti di primo grado di Youssef Lemgendez
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Youssef Lemgendez tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanderling Management CO LLC
![]() Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Investment Managers | Private Equity Investor | |
Aventis, Inc. | Corporate Officer/Principal | ||
FoldRx Pharmaceuticals LLC
![]() FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Investment Managers | Private Equity Investor | |
BIOMÉRIEUX | Medical Specialties | Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree | |
University of Montréal | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Gemin X Pharmaceuticals US, Inc.
![]() Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder | |
Ecole Nationale Supérieure de Chimie de Montpellier | College/University | Undergraduate Degree | |
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Glaxo, Inc. | Corporate Officer/Principal | ||
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
adMare Bioinnovations
![]() adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Director/Board Member | ||
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Biotechnology | President | |
Université du Québec à Montréal | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Canada | 13 |
Stati Uniti | 10 |
Regno Unito | 2 |
Francia | 2 |
Italia | 2 |
Settori
Health Technology | 13 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Posizioni
Corporate Officer/Principal | 10 |
Director/Board Member | 8 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 3 |
Graduate Degree | 3 |
Contatti più connessi
- Borsa valori
- Insiders
- Youssef Lemgendez
- Connessioni Società